NZ, I will certainly send an email.
Keeping shareholders as fully informed as they can ongoing, makes them much more tolerant when things get delayed or dont go quite as planned. It displays transparency, honesty and makes shareholders feel part of the journey which in turn breeds loyalty. Now none of that helps develop a cure for Parkinsons of course, but if they need funding any time in the future both price ( impacts dlution ) and buyers ( loyalty ) will be important.
Great company, expert talent, making wonderful progress. Just need to pay some more attention to communication.
Clinical trials do take time - provides plenty of opportunity to develop and describe the "to market" success strategy should it eventuate. A fair request.! IMO
NZ, I will certainly send an email. Keeping shareholders as...
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.7¢ | $25.64K | 3.610M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3891299 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 885009 | 4 |
View Market Depth
| Last trade - 15.29pm 03/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |